rosiglitazone has been researched along with jsh 23 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, X; Wu, G; Wu, J | 1 |
1 other study(ies) available for rosiglitazone and jsh 23
| Article | Year |
|---|---|
PPARγ activation suppresses the expression of MMP9 by downregulating NF-κB post intracerebral hemorrhage.
Topics: Anilides; Animals; Cell Line; Cerebral Hemorrhage; Disease Models, Animal; Down-Regulation; Humans; Male; Matrix Metalloproteinase 9; Mice; NF-kappa B; Phenylenediamines; PPAR gamma; Rats; Rosiglitazone | 2021 |